Registration Dossier

Diss Factsheets

Toxicological information

Carcinogenicity

Currently viewing:

Administrative data

Description of key information

Study not required as triggers in Annex X, Section 8.9.1, Column 2, of Regulation (EC) No. 1907/2006 (REACH) are not met.

Key value for chemical safety assessment

Carcinogenicity: via oral route

Endpoint conclusion
Endpoint conclusion:
no study available

Carcinogenicity: via inhalation route

Endpoint conclusion
Endpoint conclusion:
no study available

Carcinogenicity: via dermal route

Endpoint conclusion
Endpoint conclusion:
no study available

Justification for classification or non-classification

Additional information

According to Regulation (EC) No. 1907/2006 (REACH), Annex X, Section 8.9.1, Column 2, testing of carcinogenicity is not indicated, as several studies investigating the genetic toxicity of N-methyl-N-(C18-(unsaturated)alkanoyl)glycine (EC No. 701-177-3) in-vitro have shown that the substance is not genotoxic. Moreover, the subchronic repeated dose toxicity test via the oral route conducted revealed no substance-related adverse effects indicative for carcinogenicity such as hyperplasia or pre-neoplastic changes (e. g. metaplasia).